20–22 Mar 2024
Universität der Bundeswehr München
Europe/Berlin timezone

Minibeam Therapy with Lithium-7 Ions: Side Effects in Normal Brain

Not scheduled
20m
Casino (Universität der Bundeswehr München)

Casino

Universität der Bundeswehr München

Werner-Heisenberg-Weg 39 85577 Neubiberg
Oral presentation Pre-clinical studies on Particle Minibeam Therapy Pre-Clinical studies on Particle Minibeam Therapy

Speaker

John Eley (Vanderbilt University)

Description

Abstract: The purpose of this work was to investigate whether minibeam therapy with heavy ions might offer improvements of the therapeutic ratio for the treatment of human brain cancers. To assess neurotoxicity, we irradiated normal juvenile rats using 120 MeV lithium‐7 ions at an absorbed integral dose of 20 Gy. Beams were configured either as a solid parallel circular beam or as an array of planar parallel minibeams having 300‐micron width and 1‐mm center‐to‐center spacing within a circular array. We followed animals for 6 months after treatment and utilized behavioral testing and immunohistochemical studies to investigate the resulting cognitive impairment and chronic pathologic changes. We found both solid‐beam therapy and minibeam therapy to result in cognitive impairment compared with sham controls, with no apparent reduction in neurotoxicity using heavy ion minibeams instead of solid beams under the conditions of this study.

Primary author

John Eley (Vanderbilt University)

Co-authors

Catherine Haga (Vanderbilt University School of Medicine) Asaf Keller (Vanderbilt University School of Medicine) Ellis Lazenby (Vanderbilt University School of Medicine) Charles Raver (Vanderbilt University School of Medicine) Adam Rusek (Vanderbilt University School of Medicine) Avraham Dilmanian (Vanderbilt University School of Medicine) Sunil Krishnan (Vanderbilt University School of Medicine) Jaylyn Waddell (Vanderbilt University School of Medicine)

Presentation materials

There are no materials yet.